What does Hatteras Venture Partners invest in?
Hatteras Venture Partners invests most often at Series A and Series B (60% of the rounds on record), in sectors such as Biotech, Medtech and Healthtech.

United States · Investor
Last cheque observed Jul 2026; 103 cheques on record.
Deploying nowNew fund $22M, Oct 2026VC firm
Follow Hatteras Venture Partners and see its new cheques in your feed.Start following
9 cheques in the last 12 months
Mostly Series A and Series B: 60% of its rounds
Sole investor in 10 rounds, median $12M
1 exits from the portfolio
Hatteras Venture Partners is a healthcare venture capital firm investing in biotech, medtech, and healthtech companies advancing patient care.From their own website
Every round we can evidence, newest first103 appearances
8 rounds
13 rounds
10 rounds
5 rounds
4 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration18 named
We also hold 44 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
Funds on its Form ADV
4 private funds, $4.1M in gross assets · filed Sept 2024
From their own portfolio page (on their website)
Melocreative
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Companies it backed that were later bought or listed1 in all
An exit counts when it came after the firm's first round in the company. From historical deal records.
The investors most often in the same rounds as Hatteras Venture Partners. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Hatteras Venture Partners put money into.
Hatteras Venture Partners invests most often at Series A and Series B (60% of the rounds on record), in sectors such as Biotech, Medtech and Healthtech.
103 investments on record, 9 of them in the last 12 months, and it led 6. The most recent was in Jul 2026.
Its most recent investments on record: RapidPulse (Series B, Jul 2026), 410 Medical (Venture, Jul 2026) and Clearside Biomedical (Debt, Jul 2026).
The median round it joins is $20M.
Sometimes: it led 6 of its 103 investments on record (6%).
Most of the companies it backs are in the United States (100%).
Yes: it is actively investing, with 9 investments in the last 12 months.
Most often Mountain Group Partners (8 rounds together), New Enterprise Associates (7 rounds together) and Alexandria Real Estate Equities (5 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it